Comparable sales increased 4%, with growth across all segments and a particularly strong 13% contribution from emerging markets. Philips delivered €132 million of savings in Q2 and €258 million in H1, supporting a material improvement in adjusted EBITA margins. Rolling 12-month order intake rose 5%, free cash flow reached €222 million, and leverage remained manageable at approximately 1.8x EBITDA.
PHG lifts its 2026 profit and free cash flow outlook after Q2 earnings increase on higher sales, productivity gains and a U.S. tariff refund benefit.
Koninklijke Philips N.V. (PHG) Q2 2026 Earnings Call Transcript
| Health Care Equipment & Supplies Industry | Healthcare Sector | Roy W. O. Jakobs CEO | XDUS Exchange | 500472303 CUSIP |
| NL Country | 66,401 Employees | 3 Jun 2026 Last Dividend | 30 Jun 2020 Last Split | - IPO Date |
Koninklijke Philips N.V. is a global health technology company with a deep-rooted history that dates back to its founding in 1891. Headquartered in Amsterdam, the Netherlands, Philips operates on an international scale, including significant presences in North America and Greater China. The company has undergone various transformations over the years, the most notable being its name change from Koninklijke Philips Electronics N.V. to Koninklijke Philips N.V. in May 2013. Philips is segmented into three core businesses: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses, signifying its comprehensive approach to health technology. Through strategic partnerships with entities like TriHealth, Northwell, and Atrium Health, Philips is at the forefront of delivering advanced healthcare solutions around the globe.
Philips offers a wide array of imaging technologies, including magnetic resonance imaging (MRI), X-ray systems, and computed tomography (CT) systems. Their portfolio features advanced solutions such as detector-based spectral CT, alongside molecular and hybrid imaging solutions for nuclear medicine. These systems are vital in diagnostics, helping healthcare providers in various fields including cardiology and obstetrics/gynecology.
Targeting cardiology, general imaging, obstetrics/gynecology, and point-of-care applications, Philips delivers echography solutions designed for diagnosis, treatment planning, and guidance. This includes advanced technologies for monitoring heart and vascular health.
Philips excels in providing integrated interventional systems and devices aimed at treating coronary artery and peripheral vascular diseases. These are crucial for interventional diagnostics and therapeutics, blending imaging and treatment for enhanced patient outcomes.
The company’s offering extends to acute patient management, including emergency care solutions. These are complemented by sleep and respiratory care solutions, reflecting Philips' commitment to comprehensive care management across health spectrums.
Underlining its stake in the digital transformation of healthcare, Philips presents robust electronic medical record and care management systems. These solutions are designed to streamline health information management and facilitate superior care delivery.
Philips also caters to personal health through products like power toothbrushes, interdental cleaning, and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; alongside grooming and beauty products. This diverse portfolio underscores Philips' mission in enhancing health not only through medical technologies but also in everyday wellness and care.